MBD2 and neoplasm: The CKG not only automatically connected LSD1/KDM1A to tranylcypromine, the drug approved by the tumor board for our patient, but also indicated trans-2-phenylcyclopropylamine, a known potent inhibitor of the demethylase, as another treatment option55.